Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
-
Neurocrine Bio. (NBIX) PT Lowered to $105 at Cowen
-
Neurocrine Bio. (NBIX) PT Raised to $115 at Cowen
-
Neurocrine Bio. (NBIX) PT Raised to $100 at Cowen
-
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
-
Neurocrine Bio. (NBIX) PT Raised to $90 at Cowen as Ingrezza Blows Past Expectations
-
Neurocrine Biosciences (NBIX): Doubling Ingrezza Estimates - Cowen
-
Neurocrine Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference
-
UPDATE: Trading Radar for 10/29: Aetna (AET), LinkedIn (LNKD), Baidu (BIDU), ConocoPhillips (COP), MGM Resorts (MGM), Deckers (DECK) Report
-
Neurocrine Bio. (NBIX) Bullish Stance Reiterated at Cowen
-
Pre-Open Stock Movers 10/08: (JMG) (BMR) (EMC) Higher; (CSII) (ORIG) (SHAK) Lower (more...)
-
Catalyst-Rich 6 Months Ahead for Neurocrine Bio. (NBIX), Cowen Notes
-
Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
-
Trading Radar for 4/29: ExxonMobil (XOM), AIG (AIG), Visa (V), LinkedIn (LNKD), Mosaic (MOS) Report
-
Neurocrine Bio. (NBIX) Price Target Lifte at Cowen Following Dinner With Management
-
Neurocrine Biosciences (NBIX) Prices 6.9M Shares at $36/Share
-
Cowen Upgrades Neurocrine Bio. (NBIX) to Outperform
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
